Salmeterol (also known as SEREVENT) is an adrenergic receptor agonist, which is mostly prescribed for the prevention and maintenance of asthma and chronic obstructive pulmonary disease. The drug has a 12-hour duration of action and thus is more beneficial than short-acting beta2- agonists.
The increase in prevalence of people suffering from asthma and COPD, low cost of the drug, and its ability in maintaining the symptoms for long duration of time is expected to increase the demand of the drug. However, certain side-effects of the drug such as dizziness, sinus infection, migraine headaches, and breathing problems restraints the market growth.
In 2019, the market size of Salmeterol is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Salmeterol.
This report studies the global market size of Salmeterol, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Salmeterol sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Lupin Limited
MidasCare
Teva Pharmaceutical Industries
GlaxoSmithKline
Intas Pharmaceuticals
NATCO Pharma Limited
INVENT FARMA HOLDING SPAIN
Mylan
Redwing Pharma
Axa Parenterals
Market Segment by Product Type
Asthma
Bronchospasm
COPD
Others
Market Segment by Application
Clinical Research Institutes
Hospital
Surgical Centers
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Salmeterol status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Salmeterol manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Salmeterol are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
The increase in prevalence of people suffering from asthma and COPD, low cost of the drug, and its ability in maintaining the symptoms for long duration of time is expected to increase the demand of the drug. However, certain side-effects of the drug such as dizziness, sinus infection, migraine headaches, and breathing problems restraints the market growth.
In 2019, the market size of Salmeterol is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Salmeterol.
This report studies the global market size of Salmeterol, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Salmeterol sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Lupin Limited
MidasCare
Teva Pharmaceutical Industries
GlaxoSmithKline
Intas Pharmaceuticals
NATCO Pharma Limited
INVENT FARMA HOLDING SPAIN
Mylan
Redwing Pharma
Axa Parenterals
Market Segment by Product Type
Asthma
Bronchospasm
COPD
Others
Market Segment by Application
Clinical Research Institutes
Hospital
Surgical Centers
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Salmeterol status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Salmeterol manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Salmeterol are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Salmeterol Market Size Growth Rate by Type (2019-2025)
1.3.2 Asthma
1.3.3 Bronchospasm
1.3.4 COPD
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Salmeterol Market Share by Application (2019-2025)
1.4.2 Clinical Research Institutes
1.4.3 Hospital
1.4.4 Surgical Centers
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Salmeterol Market Size
2.1.1 Global Salmeterol Revenue 2014-2025
2.1.2 Global Salmeterol Sales 2014-2025
2.2 Salmeterol Growth Rate by Regions
2.2.1 Global Salmeterol Sales by Regions 2014-2019
2.2.2 Global Salmeterol Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Salmeterol Sales by Manufacturers
3.1.1 Salmeterol Sales by Manufacturers 2014-2019
3.1.2 Salmeterol Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Salmeterol Revenue by Manufacturers (2014-2019)
3.2.2 Salmeterol Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Salmeterol Market Concentration Ratio (CR5 and HHI)
3.3 Salmeterol Price by Manufacturers
3.4 Key Manufacturers Salmeterol Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Salmeterol Market
3.6 Key Manufacturers Salmeterol Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Asthma Sales and Revenue (2014-2019)
4.1.2 Bronchospasm Sales and Revenue (2014-2019)
4.1.3 COPD Sales and Revenue (2014-2019)
4.1.4 Others Sales and Revenue (2014-2019)
4.2 Global Salmeterol Sales Market Share by Type
4.3 Global Salmeterol Revenue Market Share by Type
4.4 Salmeterol Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Salmeterol Sales by Application
6 United States
6.1 United States Salmeterol Breakdown Data by Company
6.2 United States Salmeterol Breakdown Data by Type
6.3 United States Salmeterol Breakdown Data by Application
7 European Union
7.1 European Union Salmeterol Breakdown Data by Company
7.2 European Union Salmeterol Breakdown Data by Type
7.3 European Union Salmeterol Breakdown Data by Application
8 China
8.1 China Salmeterol Breakdown Data by Company
8.2 China Salmeterol Breakdown Data by Type
8.3 China Salmeterol Breakdown Data by Application
9 Rest of World
9.1 Rest of World Salmeterol Breakdown Data by Company
9.2 Rest of World Salmeterol Breakdown Data by Type
9.3 Rest of World Salmeterol Breakdown Data by Application
9.4 Rest of World Salmeterol Breakdown Data by Countries
9.4.1 Rest of World Salmeterol Sales by Countries
9.4.2 Rest of World Salmeterol Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Lupin Limited
10.1.1 Lupin Limited Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Salmeterol
10.1.4 Salmeterol Product Introduction
10.1.5 Lupin Limited Recent Development
10.2 MidasCare
10.2.1 MidasCare Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Salmeterol
10.2.4 Salmeterol Product Introduction
10.2.5 MidasCare Recent Development
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Salmeterol
10.3.4 Salmeterol Product Introduction
10.3.5 Teva Pharmaceutical Industries Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Salmeterol
10.4.4 Salmeterol Product Introduction
10.4.5 GlaxoSmithKline Recent Development
10.5 Intas Pharmaceuticals
10.5.1 Intas Pharmaceuticals Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Salmeterol
10.5.4 Salmeterol Product Introduction
10.5.5 Intas Pharmaceuticals Recent Development
10.6 NATCO Pharma Limited
10.6.1 NATCO Pharma Limited Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Salmeterol
10.6.4 Salmeterol Product Introduction
10.6.5 NATCO Pharma Limited Recent Development
10.7 INVENT FARMA HOLDING SPAIN
10.7.1 INVENT FARMA HOLDING SPAIN Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Salmeterol
10.7.4 Salmeterol Product Introduction
10.7.5 INVENT FARMA HOLDING SPAIN Recent Development
10.8 Mylan
10.8.1 Mylan Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Salmeterol
10.8.4 Salmeterol Product Introduction
10.8.5 Mylan Recent Development
10.9 Redwing Pharma
10.9.1 Redwing Pharma Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Salmeterol
10.9.4 Salmeterol Product Introduction
10.9.5 Redwing Pharma Recent Development
10.10 Axa Parenterals
10.10.1 Axa Parenterals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Salmeterol
10.10.4 Salmeterol Product Introduction
10.10.5 Axa Parenterals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Salmeterol Sales Channels
11.2.2 Salmeterol Distributors
11.3 Salmeterol Customers
12 Market Forecast
12.1 Global Salmeterol Sales and Revenue Forecast 2019-2025
12.2 Global Salmeterol Sales Forecast by Type
12.3 Global Salmeterol Sales Forecast by Application
12.4 Salmeterol Forecast by Regions
12.4.1 Global Salmeterol Sales Forecast by Regions 2019-2025
12.4.2 Global Salmeterol Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Salmeterol Market Size Growth Rate by Type (2019-2025)
1.3.2 Asthma
1.3.3 Bronchospasm
1.3.4 COPD
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Salmeterol Market Share by Application (2019-2025)
1.4.2 Clinical Research Institutes
1.4.3 Hospital
1.4.4 Surgical Centers
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Salmeterol Market Size
2.1.1 Global Salmeterol Revenue 2014-2025
2.1.2 Global Salmeterol Sales 2014-2025
2.2 Salmeterol Growth Rate by Regions
2.2.1 Global Salmeterol Sales by Regions 2014-2019
2.2.2 Global Salmeterol Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Salmeterol Sales by Manufacturers
3.1.1 Salmeterol Sales by Manufacturers 2014-2019
3.1.2 Salmeterol Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Salmeterol Revenue by Manufacturers (2014-2019)
3.2.2 Salmeterol Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Salmeterol Market Concentration Ratio (CR5 and HHI)
3.3 Salmeterol Price by Manufacturers
3.4 Key Manufacturers Salmeterol Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Salmeterol Market
3.6 Key Manufacturers Salmeterol Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Asthma Sales and Revenue (2014-2019)
4.1.2 Bronchospasm Sales and Revenue (2014-2019)
4.1.3 COPD Sales and Revenue (2014-2019)
4.1.4 Others Sales and Revenue (2014-2019)
4.2 Global Salmeterol Sales Market Share by Type
4.3 Global Salmeterol Revenue Market Share by Type
4.4 Salmeterol Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Salmeterol Sales by Application
6 United States
6.1 United States Salmeterol Breakdown Data by Company
6.2 United States Salmeterol Breakdown Data by Type
6.3 United States Salmeterol Breakdown Data by Application
7 European Union
7.1 European Union Salmeterol Breakdown Data by Company
7.2 European Union Salmeterol Breakdown Data by Type
7.3 European Union Salmeterol Breakdown Data by Application
8 China
8.1 China Salmeterol Breakdown Data by Company
8.2 China Salmeterol Breakdown Data by Type
8.3 China Salmeterol Breakdown Data by Application
9 Rest of World
9.1 Rest of World Salmeterol Breakdown Data by Company
9.2 Rest of World Salmeterol Breakdown Data by Type
9.3 Rest of World Salmeterol Breakdown Data by Application
9.4 Rest of World Salmeterol Breakdown Data by Countries
9.4.1 Rest of World Salmeterol Sales by Countries
9.4.2 Rest of World Salmeterol Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Lupin Limited
10.1.1 Lupin Limited Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Salmeterol
10.1.4 Salmeterol Product Introduction
10.1.5 Lupin Limited Recent Development
10.2 MidasCare
10.2.1 MidasCare Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Salmeterol
10.2.4 Salmeterol Product Introduction
10.2.5 MidasCare Recent Development
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Salmeterol
10.3.4 Salmeterol Product Introduction
10.3.5 Teva Pharmaceutical Industries Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Salmeterol
10.4.4 Salmeterol Product Introduction
10.4.5 GlaxoSmithKline Recent Development
10.5 Intas Pharmaceuticals
10.5.1 Intas Pharmaceuticals Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Salmeterol
10.5.4 Salmeterol Product Introduction
10.5.5 Intas Pharmaceuticals Recent Development
10.6 NATCO Pharma Limited
10.6.1 NATCO Pharma Limited Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Salmeterol
10.6.4 Salmeterol Product Introduction
10.6.5 NATCO Pharma Limited Recent Development
10.7 INVENT FARMA HOLDING SPAIN
10.7.1 INVENT FARMA HOLDING SPAIN Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Salmeterol
10.7.4 Salmeterol Product Introduction
10.7.5 INVENT FARMA HOLDING SPAIN Recent Development
10.8 Mylan
10.8.1 Mylan Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Salmeterol
10.8.4 Salmeterol Product Introduction
10.8.5 Mylan Recent Development
10.9 Redwing Pharma
10.9.1 Redwing Pharma Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Salmeterol
10.9.4 Salmeterol Product Introduction
10.9.5 Redwing Pharma Recent Development
10.10 Axa Parenterals
10.10.1 Axa Parenterals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Salmeterol
10.10.4 Salmeterol Product Introduction
10.10.5 Axa Parenterals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Salmeterol Sales Channels
11.2.2 Salmeterol Distributors
11.3 Salmeterol Customers
12 Market Forecast
12.1 Global Salmeterol Sales and Revenue Forecast 2019-2025
12.2 Global Salmeterol Sales Forecast by Type
12.3 Global Salmeterol Sales Forecast by Application
12.4 Salmeterol Forecast by Regions
12.4.1 Global Salmeterol Sales Forecast by Regions 2019-2025
12.4.2 Global Salmeterol Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
